{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:33:15Z","timestamp":1763141595374,"version":"build-2065373602"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.trre.2021.100636","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T06:40:42Z","timestamp":1624516842000},"page":"100636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference"],"prefix":"10.1016","volume":"35","author":[{"given":"Jacopo","family":"Romagnoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Acampora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viola","family":"D'Ambrosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"D'Aviero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Iezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Lancellotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Maiolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigida A.","family":"Maiorano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Posa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Preziosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Schinzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gionata","family":"Spagnoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Tanzilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Acampora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Iacovelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Iezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Schinzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Acampora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"D\u2019Aviero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Lancellotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Maiolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Posa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Scaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Schinzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gionata","family":"Spagnoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Bria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Citterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriana G.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cosmai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Di Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucrezia","family":"Furian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario Francesco","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Jereczek","family":"Fossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizam","family":"Mamode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimma","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Schinzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren Schwartz","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Vistoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Watschinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2021.100636_bb0005","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41581-018-0022-6","article-title":"Cancer in kidney transplant recipients","volume":"14","author":"Au","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2021.100636_bb0010","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2021.100636_bb0015","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1470-2045(07)70315-7","article-title":"Management of solid tumours in organ-transplant recipients","volume":"8","author":"Ajithkumar","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejca.2012.09.013","article-title":"Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009","volume":"49","author":"Piselli","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrclinonc.2015.186","article-title":"Post-transplantation malignancies: here today, gone tomorrow?","volume":"12","author":"Geissler","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/ajt.14603","article-title":"Comprehensive review of post\u2013organ transplant hematologic cancers","volume":"18","author":"Dharnidharka","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100636_bb0035","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/ajt.14238","article-title":"Chemotherapy and transplantation: the role of immunosuppression in malignancy and a review of antineoplastic agents in solid organ transplant recipients","volume":"17","author":"Krisl","year":"2017","journal-title":"Off J Am Soc Transplant Am Soc Transplant Surgeons"},{"key":"10.1016\/j.trre.2021.100636_bb0040","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1200\/JCO.2013.51.4067","article-title":"Hepatocellular carcinoma regression after cessation of immunosuppressive therapy","volume":"34","author":"Kumar","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000001447","article-title":"Cancer and mTOR inhibitors in transplant recipients","volume":"101","author":"de Fijter","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100636_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.14366","article-title":"Solid renal masses in transplanted allograft kidneys: a closer look at the epidemiology and management","author":"Griffith","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100636_bb0055","series-title":"Manuale metodologico","first-page":"2009","article-title":"Come organizzare una conferenza di consenso","author":"Candiani","year":"2009"},{"key":"10.1016\/j.trre.2021.100636_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100636_bb0065","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2021.100636_bb0070","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ijc.31769","article-title":"Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma","volume":"144","author":"Rousseau","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lungcan.2017.07.011","article-title":"Lung cancer in renal transplant recipients: a case-control study","volume":"111","author":"Rousseau-Gazaniol","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0080","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3109\/0284186X.2015.1130855","article-title":"Malignancies in transplanted patients: multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation \u2013 experiences from a prospective, clinical, observational study","volume":"55","author":"Hellstr\u00f6m","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0085","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.transproceed.2010.03.051","article-title":"Conversion to Rapamycin immunosuppression for malignancy after kidney transplantation","volume":"42","author":"Manuelli","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0090","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.14908","article-title":"Conversion to mammalian target of rapamycin inhibitors in kidney transplant recipients with de novo cancers","volume":"8","author":"Cheung","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trre.2021.100636_bb0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0100","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2016.69.3564","article-title":"Response to rituximab induction is a predictive marker in B-cell post-transplant Lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP consolidation in an international, prospective, multicenter phase II trial","volume":"35","author":"Trappe","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0105","first-page":"1774","article-title":"Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients","volume":"30","author":"Taylor","year":"2015","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc"},{"key":"10.1016\/j.trre.2021.100636_bb0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.2013.253","article-title":"Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival","volume":"85","author":"Serre","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2021.100636_bb0115","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/tri.12375","article-title":"CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality","volume":"27","author":"Rabot","year":"2014","journal-title":"Transplant Int Off J Eur Soc Organ Transplant"},{"key":"10.1016\/j.trre.2021.100636_bb0120","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.transproceed.2009.05.006","article-title":"Monotherapy rapamycin in renal transplant recipients with lymphoma successfully treated with rituximab","volume":"41","author":"Alexandru","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1442-2042.2009.02405.x","article-title":"Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years","volume":"17","author":"Abe","year":"2010","journal-title":"Int J Urol"},{"key":"10.1016\/j.trre.2021.100636_bb0130","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.17305\/bjbms.2010.2644","article-title":"Head and neck malignancies in Croatian renal transplant recipients","volume":"10","author":"Basi\u0107-Juki\u0107","year":"2010","journal-title":"Bosnian J Basic Med Sci"},{"key":"10.1016\/j.trre.2021.100636_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.transproceed.2009.11.017","article-title":"Results of the conversion to Everolimus in renal transplant recipients with Posttransplantation malignancies","volume":"42","author":"Chiurchiu","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0140","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.transproceed.2015.03.017","article-title":"Post-transplant Lymphoproliferative disorder: a single-center experience","volume":"47","author":"Ferreira","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0145","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.transproceed.2009.06.040","article-title":"Everolimus represents an advance in immunosuppression for patients who have developed cancer after renal transplantation","volume":"41","author":"Gonz\u00e1lez","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0150","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e3182551021","article-title":"Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature","author":"Nashan","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100636_bb0155","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.49.2314","article-title":"Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma","volume":"32","author":"Lipson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/tri.12834","article-title":"Mixed acute kidney allograft rejection after an antiprogrammed cell death protein 1 antibody treatment for lung epidermoid carcinoma","author":"Tamain","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100636_bb0165","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000001861","article-title":"Severe allograft rejection and autoimmune hemolytic anemia after anti-pd1 therapy in a kidney transplanted patient","author":"Deltombe","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100636_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2016.07.026","article-title":"Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient","author":"Herz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-016-0171-8","article-title":"Antitumor activity of nivolumab on hemodialysis after renal allograft rejection","author":"Ong","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2016.07.019","article-title":"Renal allograft failure after Ipilimumab therapy for metastatic melanoma: a case report and review of the literature","author":"Jose","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.13711","article-title":"Checkpoint inhibitors in kidney transplant recipients and the potential risk of rejection","author":"Alhamad","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100636_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdw130","article-title":"Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma","author":"Spain","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0195","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx409","article-title":"Tumor regression and preservation of graft function after combination with anti-PD-1 immunotherapy without immunosuppressant titration","author":"Wu","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0200","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc1614298","article-title":"Preserved renal-allograft function and the PD-1 pathway inhibitor nivolumab: to the editor","author":"Barnett","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.trre.2021.100636_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdcr.2017.06.005","article-title":"Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade","author":"Miller","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.trre.2021.100636_bb0210","doi-asserted-by":"crossref","DOI":"10.1097\/CJI.0000000000000180","article-title":"Immune checkpoint inhibitors in organ transplant patients","author":"Kittai","year":"2017","journal-title":"J Immunother"},{"key":"10.1016\/j.trre.2021.100636_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2016.12.004","article-title":"Renal complications of immune checkpoint blockade","author":"Murakami","year":"2017","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/CJI.0000000000000188","article-title":"Safe Administration of an Anti-PD-1 antibody to kidney-transplant patients: 2 clinical cases and review of the literature","author":"Winkler","year":"2017","journal-title":"J Immunother"},{"key":"10.1016\/j.trre.2021.100636_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-017-1229-z","article-title":"Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report","author":"Kwatra","year":"2017","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.trre.2021.100636_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2018.03.019","article-title":"Checkpoint blockade after kidney transplantation","author":"Lesouhaitier","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-1003-5","article-title":"PD 1 checkpoint inhibition in solid organ transplants: 2 sides of a coin - case report","author":"Goldman","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trre.2021.100636_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2018.09.017","article-title":"Anti-PD-1\/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B\/C infection","author":"Tio","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15071","article-title":"Ipilimumab for the treatment of advanced melanoma in six kidney transplant patients","author":"Zehou","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100636_bb0250","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000002502","article-title":"Preserved renal allograft function and successful treatment of metastatic Merkel cell Cancer post Nivolumab therapy","author":"Singh","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100636_bb0255","article-title":"Programmed cell death 1 (PD-1) inhibitors in renal transplant patients with advanced cancer: a double-edged sword?","author":"Lai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trre.2021.100636_bb0260","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0653-6","article-title":"Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment","author":"Hurkmans","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0265","article-title":"Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature","author":"Abdel-Wahab","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.07.005","article-title":"Immune checkpoint inhibitor therapy in solid organ transplant recipients: a patient-centered systematic review","author":"Fisher","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trre.2021.100636_bb0275","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.ackd.2016.08.002","article-title":"The bad and the good news on Cancer immunotherapy: implications for organ transplant recipients","volume":"23","author":"Maggiore","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.trre.2021.100636_bb0280","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/ajt.13786","article-title":"Use of the PD-1 pathway inhibitor Nivolumab in a renal transplant patient with malignancy","volume":"16","author":"Boils","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100636_bb0285","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1200\/JOP.2017.027326","article-title":"Complete tumor response to Pembrolizumab and allograft preservation in renal allograft recipient on immunosuppressive therapy","volume":"14","author":"Sadaat","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.trre.2021.100636_bb0290","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejca.2018.12.027","article-title":"CMV disease and colitis in a kidney transplanted patient under pembrolizumab","volume":"109","author":"Gueguen","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0295","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ekir.2019.11.015","article-title":"Systematic review of the safety of immune checkpoint inhibitors among kidney transplant patients","volume":"5","author":"Manohar","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.trre.2021.100636_bb0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.kint.2019.07.022","article-title":"Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?","volume":"97","author":"Perazella","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2021.100636_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116713","article-title":"Immune checkpoint inhibitors in non-small cell lung cancer: a bird\u2019s eye view","author":"Memon","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.trre.2021.100636_bb0310","first-page":"1","article-title":"Efficacy of immune checkpoint inhibitors in different types of melanoma","volume":"00","author":"Rossi","year":"2020","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.trre.2021.100636_bb0315","article-title":"Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysis","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2021.100636_bb0320","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-012-0242-z","article-title":"Vegf inhibition, hypertension, and renal toxicity","author":"Hayman","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.trre.2021.100636_bb0325","doi-asserted-by":"crossref","DOI":"10.1097\/SPC.0b013e32835ec861","article-title":"Mechanisms of TKI-induced diarrhea in cancer patients","author":"Bowen","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.trre.2021.100636_bb0330","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2021.100636_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2014.07.062","article-title":"Everolimus, cyclosporine, and thrombotic microangiopathy: clinical role and preventive tools in renal transplantation","author":"Nava","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0340","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-016-3033-7","article-title":"Phase I study of safety and tolerability of sunitinib in combination with sirolimus in patients with refractory solid malignancies and determination of VEGF (VEGF-A) and soluble VEGF-R2 (sVEGFR2) in plasma","author":"Li","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.trre.2021.100636_bb0345","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1470-2045(11)70124-3","article-title":"Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial","volume":"12","author":"N\u00e9grier","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0350","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant endocrine therapy for women with hormone receptor\u2013positive breast cancer: ASCO clinical practice guideline focused update","author":"Burstein","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0355","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3892\/mco.2015.615","article-title":"Chemotherapy for urothelial carcinoma in renal transplantation patients: initial results from a single center","volume":"3","author":"Zhu","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2016.02.075","article-title":"Adjuvant chemotherapy with gemcitabine plus Cisplatin for kidney transplant patients with locally advanced transitional cell carcinoma: a single-center experience","author":"Wang","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2013.06.008","article-title":"Feasibility of pre- and postoperative gemcitabine-plus-cisplatin systemic chemotherapy for the treatment of locally advanced urothelial carcinoma in kidney transplant patients","author":"Zhang","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2017.07.010","article-title":"Characteristics and long-term outcomes of head and neck squamous cell carcinoma after solid organ transplantation","author":"Alsidawi","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.trre.2021.100636_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2016.03.014","article-title":"Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies","author":"Ho","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.trre.2021.100636_bb0380","article-title":"Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: a prospective clinical trial based on cisplatin feasibility","author":"Schinzari","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.trre.2021.100636_bb0385","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.transproceed.2018.02.086","article-title":"De novo urologic malignancies in renal transplant recipients","volume":"50","author":"Antunes","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11255-011-9988-8","article-title":"Diagnosis and treatment of prostate cancer in renal-transplant recipients","volume":"44","author":"Binsaleh","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.trre.2021.100636_bb0395","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/j.clgc.2018.10.005","article-title":"Outcomes in organ transplant recipients with prostate Cancer treated with radiotherapy","volume":"17","author":"Oh","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0400","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/ctr.12773","article-title":"Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study","volume":"30","author":"Pettenati","year":"2016","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2021.100636_bb0405","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.transproceed.2018.10.027","article-title":"Low-dose-rate and high-dose-rate brachytherapy for localized prostate Cancer in ABO-incompatible renal transplant recipients","volume":"51","author":"Tasaki","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0410","doi-asserted-by":"crossref","first-page":"437","DOI":"10.18632\/oncotarget.26522","article-title":"A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature","volume":"10","author":"Velvet","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.trre.2021.100636_bb0415","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5114\/jcb.2014.40769","article-title":"Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile","volume":"6","author":"Beydoun","year":"2014","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.trre.2021.100636_bb0420","first-page":"5083","article-title":"Pelvic radiotherapy after renal transplantation","volume":"32","author":"Dahlke","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.trre.2021.100636_bb0425","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.urology.2009.06.106","article-title":"Therapeutic Management of De Novo Urological Malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux","volume":"75","author":"Elkentaoui","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.trre.2021.100636_bb0430","doi-asserted-by":"crossref","first-page":"298","DOI":"10.6002\/ect.2018.0048","article-title":"Incidence, management, and clinical outcomes of prostate Cancer in kidney transplant recipients","volume":"17","author":"Haroon","year":"2019","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.trre.2021.100636_bb0435","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.transproceed.2013.12.004","article-title":"Development of urologic de novo malignancies after renal transplantation","volume":"46","author":"Hevia","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0440","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.transproceed.2016.01.032","article-title":"Efficacy and feasibility of intensity-modulated radiation therapy for prostate Cancer in renal transplant recipients","volume":"48","author":"Iizuka","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100636_bb0445","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.30531","article-title":"Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma","author":"Kutlu","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0450","doi-asserted-by":"crossref","DOI":"10.12998\/wjcc.v7.i17.2487","article-title":"Systematic review of ablative therapy for the treatment of renal allograft neoplasms","author":"Favi","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.trre.2021.100636_bb0455","doi-asserted-by":"crossref","DOI":"10.1007\/s13244-018-0600-y","article-title":"A practical guide for planning pelvic bone percutaneous interventions (biopsy, tumour ablation and cementoplasty)","author":"O\u00f1ate Miranda","year":"2018","journal-title":"Insights Imaging"},{"key":"10.1016\/j.trre.2021.100636_bb0460","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13432","article-title":"Radiofrequency thermal ablation of renal graft neoplasms: case series and literature review","author":"Iezzi","year":"2018","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2021.100636_bb0465","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-017-1322-1","article-title":"Efficacy of percutaneous radiofrequency ablation may vary with clear cell renal cell cancer histologic subtype","author":"McClure","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.trre.2021.100636_bb0470","doi-asserted-by":"crossref","DOI":"10.5114\/jcb.2019.90466","article-title":"Critical review of multidisciplinary non-surgical local interventional ablation techniques in primary or secondary liver malignancies","author":"Kov\u00e1cs","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.trre.2021.100636_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.30101","article-title":"Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer","author":"Halpern","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.trre.2021.100636_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2009.01.018","article-title":"Radiofrequency thermal ablation of small tumors in transplanted kidneys: an evolving nephron-sparing option","author":"Veltri","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.trre.2021.100636_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2017.07.023","article-title":"Radiofrequency ablation of T1a renal cell carcinomas within renal transplant allografts: oncologic outcomes and graft viability","author":"Cool","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.trre.2021.100636_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2018.12.003","article-title":"Focal ablative therapy for renal cell carcinoma in transplant allograft kidneys","author":"Gul","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.trre.2021.100636_bb0495","doi-asserted-by":"crossref","DOI":"10.1007\/s00270-016-1531-y","article-title":"CIRSE guidelines on percutaneous ablation of small renal cell carcinoma","author":"Krokidis","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.trre.2021.100636_bb0500","doi-asserted-by":"crossref","DOI":"10.1007\/s00066-019-01501-1","article-title":"Prospective evaluation of CT-guided HDR brachytherapy as a local ablative treatment for renal masses: a single-arm pilot trial","author":"Damm","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.trre.2021.100636_bb0505","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2021.100636_bb0510","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ndt\/gfy188","article-title":"Opening an onconephrology clinic: recommendations and basic requirements","volume":"33","author":"Cosmai","year":"2018","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X21000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X21000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:07:39Z","timestamp":1760630859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X21000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0955470X21000422"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2021.100636","relation":{},"ISSN":["0955-470X"],"issn-type":[{"type":"print","value":"0955-470X"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2021.100636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100636"}}